Anti‐vascular endothelial growth factor for macular oedema secondary to central retinal vein occlusion

BACKGROUND: Central retinal vein occlusion (CRVO) is a relatively common retinal vascular disorder in which macular oedema may develop, with a consequent reduction in visual acuity. Until recently there has been no treatment of proven benefit, but growing evidence supports the use of anti‐vascular e...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Cochrane Database Syst Rev
Asıl Yazarlar: Braithwaite, Tasanee, Nanji, Afshan A, Lindsley, Kristina, Greenberg, Paul B
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley & Sons, Ltd 2014
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4292843/
https://ncbi.nlm.nih.gov/pubmed/24788977
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD007325.pub3
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller